Clinical Trial Update: The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Metamin 3D on lipid and glucose levels in subjects with metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Metamin 3D

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Metabolic Syndrome | Phase 3 | Status: COMPLETED